Experiment 1072279

Compounds isolated

Details

PropertyValue
Pharmacology
Administration routeIV
OrganismEmpty organism
CitationBEDIKIAN,AY: VALDIVIESO,M: BODEY,GP: MURPHY,WK: FREIREICH,EJ:. (1979). INITIAL CLINICAL STUDIES WITH BRUCEANTIN.. 63()
Amount utilized
Compound isolated
DiseasePHASE I CLINICAL STUDY IN 66 PATIENTS WITH VARIOUS TYPES OF ADVANCED SOLID TUMORS-DOSING DAILY X 5 DAYS HYPOTENSION WAS THE MAJOR DOSE-LIMITING TOXIC EFFECT:IT WAS DELAYED,CUMULATIVE AND OCCURRED MORE OFTEN IN PATIENTS WITH ABNORMAL PRETREATMENT LIVER FUNCTION.
Dose amount3.5 MG
Number3
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE
GenderGIVEN TO BOTH SEXES